Efficacy and safety comparison between Lenvatinib and Sorafenib in hepatocellular carcinoma treatment: a systematic review and meta-analysis of real-world study

OBJECTIVE: Our study aimed to evaluate the efficacy and safety of Lenvatinib compared with Sorafenib for treating hepatocellular carcinoma (HCC) patients under real-world setting. METHODS: We retrieved relevant literature through the PubMed, Embase, Web of Science, and Cochrane Library databases fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Hua, Xuefeng, Yin, Ziwei, Liang, Jin, Chen, Wenbin, Gong, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams And Wilkins 2023
Materias:
Original Articles: Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695342/
https://www.ncbi.nlm.nih.gov/pubmed/37942731
http://dx.doi.org/10.1097/MEG.0000000000002668

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10695342/
https://www.ncbi.nlm.nih.gov/pubmed/37942731
http://dx.doi.org/10.1097/MEG.0000000000002668

Ejemplares similares